Benuvia Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BENUVIA, and when can generic versions of BENUVIA drugs launch?
BENUVIA has one approved drug.
There are four US patents protecting BENUVIA drugs.
There are four patent family members on BENUVIA drugs in four countries.
Drugs and US Patents for Benuvia
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Benuvia Operations | SYNDROS | dronabinol | SOLUTION;ORAL | 205525-001 | Mar 23, 2017 | DISCN | Yes | No | 11,253,472 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Benuvia Operations | SYNDROS | dronabinol | SOLUTION;ORAL | 205525-001 | Mar 23, 2017 | DISCN | Yes | No | 9,345,771 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Benuvia Operations | SYNDROS | dronabinol | SOLUTION;ORAL | 205525-001 | Mar 23, 2017 | DISCN | Yes | No | 8,222,292 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Benuvia Operations | SYNDROS | dronabinol | SOLUTION;ORAL | 205525-001 | Mar 23, 2017 | DISCN | Yes | No | 10,265,293 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for BENUVIA drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Oral Solution | 5mg/ml | ➤ Subscribe | 2017-04-17 |
➤ Subscribe | Oral solution | 5 mg/mL | ➤ Subscribe | 2017-04-17 |
International Patents for Benuvia Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2010535774 | ⤷ Sign Up |
European Patent Office | 2184983 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2009020666 | ⤷ Sign Up |
Canada | 2698752 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.